AlphaYouCP
Insider selling
Christopher Peetz sold $3M of Mirum Pharmaceuticals, Inc. (MIRM) stock
Christopher Peetz, Chief Executive Officer of Mirum Pharmaceuticals, Inc. (MIRM), sold 30,000 shares of MIRM stock worth $3M, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 1, 2026, 2 days before it was made public.
MIRM has moved -6.4% since the trade date, from $98.34 to $92.00 (Sep 21, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 2 days
- Price since
- -6.4%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More MIRM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.